Bird & Bird ATMD advises iX Biopharma on rights issue

Contacts

marcus chow module
Marcus Chow

Partner
Singapore

We understand clients' needs, local markets, different business cultures.

jolie giouw module
Jolie Giouw

Partner
Singapore

I am a Partner in our Corporate and Commercial Group in Singapore. I am involved in a wide range of corporate matters across various sectors, with a focus on corporate finance as well as mergers and acquisitions.

xingyi tan module
Xing Yi Tan

Senior Associate
Singapore

I am a senior associate in Bird & Bird ATMD's Corporate & Commercial Group, based in Singapore. My key areas of practice include equity capital markets and mergers and acquisitions.

Bird & Bird ATMD is pleased to advise iX Biopharma, a Singapore Exchange (SGX) listed pharmaceutical company, on its renounceable non-underwritten rights issue.

Under the rights issue, each eligible shareholder can subscribe for 11 rights shares at an issue price of S$0.03 per share for every 50 existing shares held in iX Biopharma as at record date 26 June 2024. Additionally, for every two rights shares subscribed, one free warrant will be issued, allowing the holder to purchase one new share in the company at S$0.06.

iX Biopharma is undertaking the rights cum warrants issue to raise funds to, amongst others, advance the development of iXB 401 sublingual semaglutide wafers as a treatment for Type 2 diabetes and obesity, as well as to fund the sales and marketing activities of its innovative supplements including NAD+ sublingual wafers. 

Bird & Bird’s team was led by Corporate Partner Marcus Chow and supported by Counsel Jolie Giouw and Associate Tan Xing Yi.

News & Deals

More News & Deals
News Bird & Bird Advises Ratiopharm in Landmark Xarelto Patent Revocation Case

Aug 01 2025

Read More
Deal Bird & Bird advises Everystate on its seed funding round

Jul 30 2025

Read More
Deal Bird & Bird advises Marylebone Cricket Club on landmark London Spirit stake transfer

Jul 30 2025

Read More
Deal Bird & Bird advises Bpifrance's SPI 2 fund on Khimod's €23 million fundraising

Jul 29 2025

Read More
News Bird & Bird hires Restructuring & Insolvency team in Singapore

Jul 28 2025

Read More
Deal Bird & Bird advises Akiem on the acquisition, financing and leasing of a fleet of 14 battery-powered electric trains

Jul 22 2025

Read More